The National Agency for Food and Drug Administration and Control (NAFDAC) vaccine committee has approved the emergency use of additional three new Covid-19 vaccines. x“AstraZeneca AZD1222 Vaccine AstraZeneca AZD1222 COVID-19 vaccine is a recombinant ChAdOx1 adenoviral vector encoding the structural surface glycoprotein (Spike protein) antigen of the SARS-CoV-2 from SK Bioscience Co Limited (Republic of Korea). Sputnik V Vaccine The Gam-COVID-Vac COVID-19 Vaccine is supplied as a two-component product, both of which are 3ml (5 doses) solution for intramuscular injection in glass vial. She said this mechanism explained is in guidance developed by the COVID-19 Vaccine Committee. “NAFDAC is the first National Regulatory Agency in Africa to have Guidance on Regulatory Preparedness for EUA, Licensing or Access to COVID-19 Vaccines,” Adeyeye said.

Source: The Guardian July 15, 2021 11:03 UTC